Clinical Trials
CTI BioPharma Initiates Phase III Pacritinib Trial in COVID-19
CTI BioPharma Corp. initiated PRE-VENT, a Phase III study evaluating pacritinib in hospitalized patients with severe COVID-19. PRE-VENT, a randomized, double-blind, placebo-controlled study, will compare pacritinib plus standard of care (SOC) versus placebo plus standard of care in 358...
Articles
COVID-19: A catalyst for change in global clinical trials
The COVID-19 pandemic has exposed some significant frailties in the physical clinical supply chain. As governments, medical professionals and life science organisations around the world direct their energy and resources to curtailing the pandemic, a challenge that requires attention,...
Clinical Trials
Queen’s University leading cell therapy clinical trial to help improve outcomes in COVID-19 patients
Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure.
This clinical trial, led by Professor Danny McAuley and Professor Cecilia O’Kane, both researchers from the...
Clinical Trials
Pfizer and BioNTech Aim to Start Testing Coronavirus Vaccines in Humans by Late April
Pfizer and BioNTech announced that they intend to advance multiple SARS-CoV-2 vaccine candidates into human clinical testing, with the first clinical trials potentially beginning by late April. The two companies began their collaboration focused on developing a vaccine for...
Clinical Trials
A World Pharma Today exclusive with Jim Murphy, CEO, Greenphire
Who would have thought a pandemic in this modern era would cripple the world, the strongest economies would be shaken, and end up being so vulnerable despite having the most modern technologies and processes at our disposal. That being...
Clinical Trials
Leading Life Sciences and Information Technology Companies Join EndPandemic National Data Consortium to Integrate COVID-19 Clinical Data
The EndPandemic National Data Consortium announced that it has received commitments from six leading life sciences and information technology companies to join the Consortium, the formation of which was announced on March 30, 2020. The companies will work together...
Clinical Trials
APEIRON Biologics InitiatesPhase II Clinical Trial of APN01 for Treatment of COVID-19
APEIRON Biologics AG announced that it has received regulatory approvals in Austria, Germany and Denmark to initiate a Phase II clinical trial of APN01 to treat COVID-19. APN01 is the recombinant form of the human angiotensin-converting enzyme 2 (rhACE2),...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.